PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26462028-4	2015	Blocking TGF-beta signaling with the TGF-beta type I receptor kinase (ALK5) inhibitor, EW-7197, suppresses paclitaxel-induced EMT and CSC properties such as mammosphere-forming efficiency (MSFE), aldehyde dehydrogenase (ALDH) activity, CD44+/CD24- ratio, and pluripotency regulators (Oct4, Nanog, Klf4, Myc, and Sox2).	Paclitaxel	107-117	Nanog homeobox	Homo sapiens	290-295	
34610216-7	2021	RESULTS: The expression levels of C-MYC and NANOG were significantly higher in paclitaxel-resistant PC-3 cells compared to the parental PC-3 cells.	Paclitaxel	79-89	Nanog homeobox	Homo sapiens	44-49	
32986398-0	2020	Internal Oligoguanidinium Transporter: Mercury Free Scalable Synthesis, Improvement of Cellular Localization, Endosomal Escape, Mitochondrial Localization and Conjugation with Antisense Morpholino for NANOG Inhibition to Induce Chemosensitisation of Taxol in MCF-7 Cells.	Paclitaxel	250-255	Nanog homeobox	Homo sapiens	201-206	
32986398-8	2020	To the best of our knowledge, this is the first report to illustrate that the IGT-PMO-mediated NANOG inhibition increases the therapeutic potential of taxol and induces G0-G1 arrest in cancer cells to prevent the cancer progression.	Paclitaxel	151-156	Nanog homeobox	Homo sapiens	95-100	
32779438-10	2020	Overexpression of GATA5 also promoted Paclitaxel to inhibit expression of reprogramming genes, such as Nanog, EpCAM, c-Myc and Sox2 in Bel7402 and PLC/PRF/5 cells.	Paclitaxel	38-48	Nanog homeobox	Homo sapiens	103-108	
31867270-10	2019	In order to test this, we generated a paclitaxel-resistant TNBC cell line which demonstrated an elevated level of eIF4A along with increased levels of cancer stemness markers (ALDH activity and CD44), pluripotency transcription factors (SOX2, OCT4, and NANOG) and drug transporters (ABCB1, ABCG2, and ABCC1).	Paclitaxel	38-48	Nanog homeobox	Homo sapiens	253-258	
33599261-0	2021	Nanog-mediated stem cell properties is critical for MBNL3 associated paclitaxel resistance of ovarian cancer.	Paclitaxel	69-79	Nanog homeobox	Homo sapiens	0-5	
33599261-8	2021	This study suggests the MBNL3-Nanog axis is a therapeutic target for the treatment of PTX-resistance in ovarian cancer management.	Paclitaxel	86-89	Nanog homeobox	Homo sapiens	30-35	
32254809-5	2019	The results of the role of autophagy in the sensitivity of chemotherapeutic PTX to glioma cells showed that the stemness-associating genes (SOX2, POU5F1 and NANOG) of live glioma cells increased in the presence of PTX, while they dropped sharply with the combination including CQ.	Paclitaxel	76-79	Nanog homeobox	Homo sapiens	157-162	
23095773-2	2012	METHODS: The expression of NANOG was evaluated in 6 ovarian carcinoma cell lines, paclitaxel-resistant SKOV3 cells, and SKOV3 spheroid cells with semiquantitative reverse transcription-polymerase chain reaction and Western blotting.	Paclitaxel	82-92	Nanog homeobox	Homo sapiens	27-32	
23095773-6	2012	The mRNA level of NANOG was increased in the paclitaxel-resistant SKOV3 cells and SKOV3 spheroid cells compared with that in the SKOV3 cells.	Paclitaxel	45-55	Nanog homeobox	Homo sapiens	18-23